{"id":"https://openalex.org/W4403391908","doi":"https://doi.org/10.1136/gutjnl-2024-basl.53","title":"P44 Clinical outcomes, safety and length of stay for patients receiving transarterial chemoembolisation (TACE): a retrospective audit","display_name":"P44 Clinical outcomes, safety and length of stay for patients receiving transarterial chemoembolisation (TACE): a retrospective audit","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403391908","doi":"https://doi.org/10.1136/gutjnl-2024-basl.53"},"language":"en","primary_location":{"id":"doi:10.1136/gutjnl-2024-basl.53","doi":"https://doi.org/10.1136/gutjnl-2024-basl.53","is_oa":false,"landing_page_url":"https://doi.org/10.1136/gutjnl-2024-basl.53","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"P44\u2005Clinical outcomes, safety and length of stay for patients receiving transarterial chemoembolisation (TACE): a retrospective audit","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113064564","display_name":"Keurene Kasongo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7882870","display_name":"University of Glasgow","ror":"https://ror.org/00vtgdb53","country_code":"GB","type":"education","lineage":["https://openalex.org/I7882870"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Keurene Kasongo","raw_affiliation_strings":["University of Glasgow, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Glasgow, Glasgow, UK","institution_ids":["https://openalex.org/I7882870"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006670345","display_name":"Rachael E. Swann","orcid":"https://orcid.org/0000-0002-3945-2253","observed_orcids":["https://orcid.org/0000-0002-3945-2253"]},"institutions":[{"id":"https://openalex.org/I4210158502","display_name":"Queen Elizabeth University Hospital","ror":"https://ror.org/04y0x0x35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399","https://openalex.org/I4210158502"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rachael Swann","raw_affiliation_strings":["Queen Elizabeth University Hospital, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Elizabeth University Hospital, Glasgow, UK","institution_ids":["https://openalex.org/I4210158502"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113959671","display_name":"Matthew Priest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210158502","display_name":"Queen Elizabeth University Hospital","ror":"https://ror.org/04y0x0x35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399","https://openalex.org/I4210158502"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Matthew Priest","raw_affiliation_strings":["Queen Elizabeth University Hospital, Glasgow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Elizabeth University Hospital, Glasgow, UK","institution_ids":["https://openalex.org/I4210158502"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A38.2","last_page":"A39"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/transarterial-chemoembolization","display_name":"transarterial chemoembolization","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.8960000276565552},{"id":"https://openalex.org/keywords/child-pugh-score","display_name":"Child-Pugh score","score":0.8999999761581421},{"id":"https://openalex.org/keywords/meld-score","display_name":"MELD score","score":0.9869999885559082},{"id":"https://openalex.org/keywords/disease-control","display_name":"disease control","score":0.6669999957084656},{"id":"https://openalex.org/keywords/locally-advanced-liver-cancer","display_name":"locally advanced liver cancer","score":0.7110000252723694},{"id":"https://openalex.org/keywords/palliative-care","display_name":"palliative care","score":0.5860000252723694},{"id":"https://openalex.org/keywords/liver-infarction","display_name":"liver infarction","score":0.6069999933242798},{"id":"https://openalex.org/keywords/cholecystitis","display_name":"cholecystitis","score":0.8849999904632568},{"id":"https://openalex.org/keywords/abscess-formation","display_name":"abscess formation","score":0.7710000276565552},{"id":"https://openalex.org/keywords/tumor-characteristics","display_name":"tumor characteristics","score":0.5019999742507935},{"id":"https://openalex.org/keywords/patient-demographics","display_name":"patient demographics","score":0.5740000009536743},{"id":"https://openalex.org/keywords/nhs-greater-glasgow-and-clyde","display_name":"NHS Greater Glasgow and Clyde","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C199521495","wikidata":"https://www.wikidata.org/wiki/Q181487","display_name":"Audit","level":2,"score":0.7156404256820679},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6566329002380371},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.6051632165908813},{"id":"https://openalex.org/C2779328685","wikidata":"https://www.wikidata.org/wiki/Q1475557","display_name":"Patient safety","level":3,"score":0.44518184661865234},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21585732698440552},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.12952148914337158},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.06892386078834534},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/gutjnl-2024-basl.53","doi":"https://doi.org/10.1136/gutjnl-2024-basl.53","is_oa":false,"landing_page_url":"https://doi.org/10.1136/gutjnl-2024-basl.53","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"P44\u2005Clinical outcomes, safety and length of stay for patients receiving transarterial chemoembolisation (TACE): a retrospective audit","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W3108674512","https://openalex.org/W1506200166","https://openalex.org/W1489783725","https://openalex.org/W2148612803"],"abstract_inverted_index":{"Introduction":[0],"Hepatocellular":[1],"carcinoma":[2],"(HCC)":[3],"is":[4,62,71],"the":[5,32,46,51,104,109,122,185,202,208,297,304,319],"most":[6,186],"common":[7],"form":[8],"of":[9,14,26,34,108,116,124,126,170,173,176,210,212,236,306,311,321,335,345,358,372],"primary":[10],"liver":[11,20,118,259],"cancer,":[12],"90%":[13],"cases":[15],"are":[16,56],"associated":[17,195],"with":[18,286,327,332,347],"chronic":[19],"disease.":[21],"Early":[22],"detection":[23],"and":[24,114,130,146,160,180,193,207,215,261,299,309,370],"management":[25],"HCC":[27,68],"remain":[28],"challenging":[29],"due":[30],"to":[31,88,92,165,200,283],"lack":[33],"specific":[35],"symptoms.":[36],"Despite":[37],"wide":[38],"spread":[39],"surveillance":[40],"programmes":[41],"for":[42,67],"at":[43,99,223,266],"risk":[44,334],"patients,":[45,346],"majority":[47,320],"patients":[48,91,127,141,228,248,272,322],"present":[49],"beyond":[50],"stage":[52,82,90],"where":[53],"curative":[54,94],"treatments":[55],"an":[57,328],"option.":[58],"Transarterial":[59],"chemo-embolisation":[60],"(TACE)":[61],"a":[63,73],"commonly":[64],"used":[65,76,87],"treatment":[66,75],"treatment.":[69],"It":[70],"principally":[72],"palliative":[74],"in":[77,318,343,356],"locally":[78],"advanced":[79],"disease":[80,119,275,290],"(BCLC":[81],"B),":[83],"but":[84],"can":[85,324],"be":[86,325],"down":[89],"allow":[93],"options.":[95],"This":[96,135,314],"audit":[97,137,315],"looks":[98],"whether":[100],"factors":[101,206],"such":[102],"as":[103],"patient":[105,368],"demographic,":[106],"characteristic":[107],"tumor,":[110],"Child":[111],"Pugh":[112],"score":[113],"Model":[115],"end-stage":[117],"(MELD)":[120],"affect":[121],"length":[123,209,235,310,371],"stay":[125,211,238,374],"post":[128,253],"TACE,":[129,285],"their":[131,161],"clinical":[132,216],"outcomes.":[133],"Method":[134],"retrospective":[136],"analysed":[138,199],"data":[139],"from":[140],"across":[142],"NHS":[143],"Greater":[144],"Glasgow":[145],"Clyde":[147],"who":[148],"received":[149],"TACE":[150,177,188,254,323],"between":[151,204,296,364],"August":[152],"2022":[153],"\u2013":[154],"September":[155],"2023.":[156],"Patients":[157],"were":[158,229],"identified":[159,230],"medical":[162],"records":[163],"accessed":[164],"obtain":[166],"information":[167],"on;":[168],"date":[169],"diagnosis,":[171],"number/size":[172],"tumor(s),":[174],"number":[175,298,305],"sessions,":[178],"MELD":[179],"Child-Pugh":[181],"score.":[182],"We":[183],"reviewed":[184],"recent":[187],"session":[189],"within":[190],"this":[191],"window":[192],"any":[194],"complications.":[196],"Data":[197],"was":[198,240,293,341,362],"assess":[201],"correlation":[203,295,361],"these":[205],"each":[213],"patient,":[214],"outcomes":[217],"based":[218],"on":[219,352],"follow":[220,353],"up":[221,354],"imaging":[222,265,355],"4\u20136":[224],"weeks.":[225],"Results":[226],"42":[227],"(figure":[231],"1).":[232],"The":[233],"median":[234],"hospital":[237,330,373],"post-TACE":[239],"1.5":[241],"days":[242],"(Range":[243],"1\u201314":[244],"days).":[245],"Only":[246],"2":[247],"(4.8%)":[249],"experienced":[250],"significant":[251,336],"complications":[252],"(1":[255],"acute":[256],"cholecystitis,":[257],"1":[258],"infarction":[260],"abscess":[262],"formation).":[263],"Follow-up":[264],"4-":[267],"6":[268],"weeks,":[269],"demonstrated":[270],"14":[271],"(33%)":[273],"achieved":[274],"control,":[276],"18":[277],"(43%)":[278],"had":[279,289],"viable":[280,349],"tumour":[281,350],"amenable":[282],"further":[284],"10":[287],"(24%)":[288],"progression.":[291],"There":[292],"no":[294,348],"size":[300],"lesions":[301],"treated":[302],"or":[303,367,375],"previous":[307],"treatments,":[308],"stay.":[312],"Conclusion":[313],"demonstrates":[316],"that":[317],"delivered":[326],"overnight":[329],"stay,":[331],"low":[333],"adverse":[337],"events.":[338],"Disease":[339],"progression":[340],"prevented":[342],"76%":[344],"seen":[351],"33%":[357],"patients.":[359],"No":[360],"found":[363],"tumor":[365],"characteristics":[366],"demographics":[369],"complication":[376],"rates.":[377]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2025-10-10T00:00:00"}